Seidman S L, Witney F R, Surzycki S J
Mol Gen Genet. 1980;179(3):647-59. doi: 10.1007/BF00271754.
The interaction of Adenovirus 2 DNA and human placental RNA polymerase II in vitro satisfies criteria that suggest that at least some fraction of our purified polymerase preparations corresponds to prokaryotic holoenzyme and is able to initiate transcription at "true" promoters: (1) The purified enzyme forms highly stable complexes at specific sites on Ad 2 DNA; Kass = 1--2 X 10(12) M-1. (2) Transcription of Ad 2 DNA from pre-formed complexes with human RNA polymerase II is resistant to poly I. (3) Many of the stable-binding sites correspond to Ad 2 promoters known to be active in vivo. We also present evidence consistent with a two-state (I and RS) model (Chamberlin et al. 1976; Travers 1974) for the interaction of human RNA polymerase II with Ad 2 DNA. These experiments, which are similar to those described previously in studies of wheat germ RNA polymerase II (Seidman et al. 1979), indicate that the mechanisms of transcription inhibition and promoter site selection in eukaryotic and prokaryotic systems may be very similar.
腺病毒2型DNA与人类胎盘RNA聚合酶II在体外的相互作用符合一些标准,这些标准表明我们纯化的聚合酶制剂中至少有一部分相当于原核全酶,并且能够在“真正的”启动子处起始转录:(1)纯化的酶在腺病毒2型DNA的特定位点形成高度稳定的复合物;结合常数Kass = 1 - 2×10¹² M⁻¹。(2)从与人类RNA聚合酶II预先形成的复合物对腺病毒2型DNA进行转录时,对多聚肌苷酸具有抗性。(3)许多稳定结合位点对应于已知在体内具有活性的腺病毒2型启动子。我们还提供了与人类RNA聚合酶II与腺病毒2型DNA相互作用的双态(I和RS)模型(钱伯林等人,1976年;特拉弗斯,1974年)相一致的证据。这些实验与之前在小麦胚芽RNA聚合酶II研究中描述的实验(西德曼等人,1979年)相似,表明真核和原核系统中转录抑制和启动子位点选择的机制可能非常相似。